Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07729709Phase 3Completed
Phase 3, randomised trial in chronic anal fissure (CAF) (2 arms), sponsored by Galala University. Primary endpoints: The Realise score at 4 weeks and World Health Organization Quality of Life - Brief at 4 weeks. Started Jan 2026; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07729709.